These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19436123)

  • 21. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens.
    Onouchi Z; Hamaoka K; Sakata K; Ozawa S; Shiraishi I; Itoi T; Kiyosawa N
    Circ J; 2005 Mar; 69(3):265-72. PubMed ID: 15731529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National Japanese survey of thrombolytic therapy selection for coronary aneurysm: intracoronary thrombolysis or intravenous coronary thrombolysis in patients with Kawasaki disease.
    Harada M; Akimoto K; Ogawa S; Kato H; Nakamura Y; Hamaoka K; Saji T; Shimizu T; Kato T
    Pediatr Int; 2013 Dec; 55(6):690-5. PubMed ID: 23919576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Author's Reply.
    Su D; Wang K; Qin S; Pang Y
    Cardiology; 2015; 130(3):166. PubMed ID: 25676687
    [No Abstract]   [Full Text] [Related]  

  • 24. Serious sequels of Kawasaki disease.
    Kim NS; Menahem S
    Cardiol Young; 1998 Jul; 8(3):386-9. PubMed ID: 9731656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary artery aneurysm in Kawasaki disease: from multimodality imaging.
    Lee CH; Kim U
    Coron Artery Dis; 2020 Mar; 31(2):193-194. PubMed ID: 31821196
    [No Abstract]   [Full Text] [Related]  

  • 26. Pediatric Thromboprophylaxis of Large Coronary Artery Aneurysm Using Rivaroxaban.
    Montanez N; Sexson Tejtel SK; Menon NM
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):356-359. PubMed ID: 37314881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flying with giant coronary aneurysms caused by Kawasaki disease.
    Teramachi Y; Suda K; Ogawa S; Kamiyama H; Hamaoka K
    Int J Cardiol; 2013 Oct; 168(5):4964-5. PubMed ID: 23916775
    [No Abstract]   [Full Text] [Related]  

  • 28. Histopathologic and coronary angiographic assessment of effectiveness of aspirin or aspirin-and-gammaglobulin in Kawasaki disease.
    Haneda N; Mori C
    Acta Paediatr Jpn; 1993 Aug; 35(4):294-7. PubMed ID: 7691025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strict management of a pregnant patient with giant coronary artery aneurysm due to Kawasaki disease.
    Taniguchi K; Ono H; Sato A; Kinomoto S; Tagawa N; Umehara N; Kato H; Sago H
    Pediatr Int; 2015 Oct; 57(5):990-2. PubMed ID: 26171683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombolytic therapy in Kawasaki disease: a report of four cases.
    Harada M; Akimoto K; Otaka M; Sato K; Oda H; Otsuki M; Takahashi K; Kishiro M; Shimizu T
    Pediatr Int; 2013 Oct; 55(5):e111-5. PubMed ID: 24134762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary thrombosis and myocardial ischemia in Kawasaki disease: a case report.
    Gao L; Xie C; Zhang Q; Wang X; Fu S; Hu J; Zhang Y; Gong F
    BMC Cardiovasc Disord; 2024 Sep; 24(1):473. PubMed ID: 39237865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follow-up of coronary artery lesions caused by Kawasaki disease and the value of coronary angiography.
    Gong F; Shiraishi H; Momoi MY
    Chin Med J (Engl); 2002 May; 115(5):681-4. PubMed ID: 12133534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nationwide survey of coronary aneurysms with diameter >6 mm in Kawasaki disease in Korea.
    Jang GY; Kang IS; Choi JY; Bae EJ; Kim YH; Kim SH; Ma JS
    Pediatr Int; 2015 Jun; 57(3):367-72. PubMed ID: 25406095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlates of coronary artery aneurysm formation in patients with Kawasaki disease.
    Daniels SR; Specker B; Capannari TE; Schwartz DC; Burke MJ; Kaplan S
    Am J Dis Child; 1987 Feb; 141(2):205-7. PubMed ID: 3812389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression and Complications of z-score-Based Giant Aneurysms in a Dutch Cohort of Kawasaki Disease Patients.
    Dietz SM; Kuipers IM; Koole JCD; Breur JMPJ; Fejzic Z; Frerich S; Dalinghaus M; Roest AAW; Hutten BA; Kuijpers TW
    Pediatr Cardiol; 2017 Apr; 38(4):833-839. PubMed ID: 28236162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of Kawasaki disease with giant coronary aneurysms: a single-centre study in southwest China.
    Yuan P; Su D; Mandal KD; Qin S; Zhao N; Pang Y
    Cardiol Young; 2020 Jun; 30(6):834-839. PubMed ID: 32508295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of thrombosis in KD Patients using tissue plasminogen activator: a single center study.
    Chu Y; Xu Y; Wang C; Yu X; Ma Q; Wang H
    Pediatr Rheumatol Online J; 2022 Dec; 20(1):111. PubMed ID: 36471358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Improving the diagnosis and therapy of Kawasaki disease].
    Du JB
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):321-3. PubMed ID: 16780704
    [No Abstract]   [Full Text] [Related]  

  • 39. The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976.
    McNeal-Davidson A; Fournier A; Scuccimarri R; Dancea A; Houde C; Bellavance M; Dahdah N
    Pediatr Cardiol; 2013 Jan; 34(1):170-8. PubMed ID: 22706758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Giant coronary artery aneurysms complicating Kawasaki disease in Mexican children.
    Garrido-García LM; Morán-Villaseñor E; Yamazaki-Nakashimada MA; Cravioto P; Galván F
    Cardiol Young; 2018 Mar; 28(3):386-390. PubMed ID: 28847341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.